S. Ball

3.2k total citations · 1 hit paper
28 papers, 2.3k citations indexed

About

S. Ball is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, S. Ball has authored 28 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 12 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in S. Ball's work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (10 papers) and Carcinogens and Genotoxicity Assessment (3 papers). S. Ball is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (10 papers) and Carcinogens and Genotoxicity Assessment (3 papers). S. Ball collaborates with scholars based in United States, United Kingdom and Canada. S. Ball's co-authors include JoAnn Scatina, Ruth Hyland, Barry Jones, Susan Hurst, Dennis A. Smith, J. Andrew Williams, Jeffrey R. Koup, Vincent Peterkin, Theunis C. Goosen and John Y. Kao and has published in prestigious journals such as Nature Biotechnology, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

S. Ball

28 papers receiving 2.2k citations

Hit Papers

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SU... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
    2004 687 citations J. Andrew Williams, Ruth Hyland et al. Drug Metabolism and Disposition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ball United States 21 1.5k 745 599 295 256 28 2.3k
Regina W. Wang United States 22 1.1k 0.7× 646 0.9× 494 0.8× 211 0.7× 220 0.9× 32 1.9k
Thomas Kronbach Switzerland 25 1.6k 1.0× 929 1.2× 677 1.1× 379 1.3× 421 1.6× 37 2.6k
A. Parkinson United States 29 1.2k 0.8× 522 0.7× 564 0.9× 319 1.1× 133 0.5× 56 2.6k
Robert L. Haining United States 23 1.7k 1.1× 856 1.1× 410 0.7× 401 1.4× 282 1.1× 28 2.3k
Slobodan Rendić Croatia 20 2.1k 1.4× 972 1.3× 870 1.5× 369 1.3× 229 0.9× 45 3.2k
Cosette J. Serabjit‐Singh United States 24 1.2k 0.8× 1.3k 1.7× 883 1.5× 263 0.9× 463 1.8× 40 3.1k
Jean‐Charles Gautier France 27 1.2k 0.8× 646 0.9× 852 1.4× 239 0.8× 209 0.8× 60 2.8k
Toshiro Niwa Japan 27 1.1k 0.7× 505 0.7× 452 0.8× 258 0.9× 220 0.9× 98 2.2k
Mark VandenBranden United States 24 2.4k 1.5× 1.3k 1.8× 615 1.0× 361 1.2× 492 1.9× 28 3.1k
A. David Rodrigues United States 33 1.8k 1.2× 1.1k 1.5× 619 1.0× 406 1.4× 362 1.4× 68 3.0k

Countries citing papers authored by S. Ball

Since Specialization
Citations

This map shows the geographic impact of S. Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ball more than expected).

Fields of papers citing papers by S. Ball

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ball. The network helps show where S. Ball may publish in the future.

Co-authorship network of co-authors of S. Ball

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ball. A scholar is included among the top collaborators of S. Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ball. S. Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, J. Andrew, Ruth Hyland, Barry Jones, et al.. (2004). DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS. Drug Metabolism and Disposition. 32(11). 1201–1208. 687 indexed citations breakdown →
2.
Williams, John A., Susan Hurst, Jonathan Bauman, et al.. (2003). Reaction Phenotyping in Drug Discovery: Moving Forward with Confidence?. Current Drug Metabolism. 4(6). 527–534. 39 indexed citations
3.
Yengi, Lilian, Qian Xiang, Jinmei Pan, et al.. (2003). Quantitation of cytochrome P450 mRNA levels in human skin. Analytical Biochemistry. 316(1). 103–110. 77 indexed citations
4.
Pan, Jinmei, Qian Xiang, S. Ball, et al.. (2003). Lipopolysaccharide-Mediated Modulation of Cytochromes P450 in Stat1 Null Mice. Drug Metabolism and Disposition. 31(4). 392–397. 15 indexed citations
5.
Renwick, A. B., S. Ball, J. Michael Tredger, et al.. (2002). Inhibition of zaleplon metabolism by cimetidine in the human liver:in vitrostudies with subcellular fractions and precision-cut liver slices. Xenobiotica. 32(10). 849–862. 52 indexed citations
6.
Lake, Brian G., et al.. (2002). Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica. 32(10). 835–847. 71 indexed citations
7.
8.
Ball, S., JoAnn Scatina, John Y. Kao, et al.. (1999). Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4. Clinical Pharmacology & Therapeutics. 66(3). 288–294. 198 indexed citations
9.
10.
Renwick, A. B., et al.. (1998). Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica. 28(4). 337–348. 42 indexed citations
11.
Lake, Brian G., S. Ball, A. B. Renwick, et al.. (1997). Induction of CYP3A isoforms in cultured precisioncut human liver slices. Xenobiotica. 27(11). 1165–1173. 31 indexed citations
12.
13.
Otton, S V, S. Ball, Siu Wah Cheung, et al.. (1996). Venlafaxine oxidationin vitrois catalysed by CYP2D6. British Journal of Clinical Pharmacology. 41(2). 149–156. 189 indexed citations
14.
15.
Ball, S., JoAnn Scatina, Samuel F. Sisenwine, & G. L. Fisher. (1995). The Application of In Vitro Models of Drug Metabolism and Toxicity in Drug Discovery and Drug Development. Drug and Chemical Toxicology. 18(1). 1–28. 24 indexed citations
16.
Ball, S., Gerald Maurer, Markus Zollinger, Margarita G. Ladona, & Alison E.M. Vickers. (1992). Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.. Drug Metabolism and Disposition. 20(1). 56–63. 34 indexed citations
17.
Forrester, Lesley M., Colin J. Henderson, David Back, et al.. (1992). Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal. 281(2). 359–368. 212 indexed citations
18.
Orme, Michael, D.J. Back, & S. Ball. (1989). Interindividual variation in the metabolism of ethynylestradiol. Pharmacology & Therapeutics. 43(2). 251–260. 32 indexed citations
19.
Smith, E. Lester, et al.. (1952). B12 vitamins (cobalamins). 1. Vitamins B12c and B12d. Biochemical Journal. 52(3). 389–395. 13 indexed citations
20.
Ball, S., et al.. (1951). Vitamin B12; additional factors.. PubMed. 48(4). l–li. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina W. Wang Breakdown of academic impact, for papers by Thomas Kronbach Breakdown of academic impact, for papers by A. Parkinson Breakdown of academic impact, for papers by Robert L. Haining Breakdown of academic impact, for papers by Slobodan Rendić Breakdown of academic impact, for papers by Cosette J. Serabjit‐Singh Breakdown of academic impact, for papers by Jean‐Charles Gautier Breakdown of academic impact, for papers by Toshiro Niwa Breakdown of academic impact, for papers by Mark VandenBranden Breakdown of academic impact, for papers by A. David Rodrigues
Rankless by CCL
2026